Torsten Maehle, CEO of Vaxxinator USA and founder of Atmofizer, examines how the coronavirus pandemic has impacted how we view the air around us, and why we also need to shift our focus to ultra fine particles in order to maintain a healthy life.
After spending the past year navigating life with COVID, wearing masks every day and in some cases multiple masks at a time, people have been forced to reckon with the air that they breathe and assess their safety and health in any given situation or location. Dealing with an airborne virus has presented many challenges to both individuals and businesses, and it has brought a lot of questions to the forefront as we reconsider our comfort levels moving forward.
The positive news is that there are a variety of new and approved vaccines on the market today that will hopefully be distributed quickly and efficiently in an effort to minimize and eliminate the spread of COVID-19 completely.
The flipside to that, however, is that there are still ultra fine particles and pollutants that affect our breathing every day and can result in many other illnesses. Asthma and Chronic Obstructive Pulmonary Disease or COPD are among the most common lung issues, but even everyday allergens, bacteria, chemicals, and other viruses that can have an impact on our overall health and wellness. Worldwide 235 million people suffer from asthma, and approximately 3 million people die each year from COPD, , making it the third leading cause of death worldwide.
That’s why my team and I have worked to develop Atmofizer, a revolutionary product that inactivates ultra fine particles from polluted air. Many people don’t know, but COVID-19 and other common viruses are the same size. It will be the key to not only safely reopening businesses around the country and around the world, but this is an innovation in air purifying technology that will disrupt the industry for years to come. We really strived to create something that has never been done before in terms of technology, and we succeeded. The technology is not only superior in terms of capability in destroying harmful particles, but it is also chemical-free unlike ionization systems. It doesn’t take a lot of space, doesn’t require filter changes, and therefore there is no landfill waste.
The ethical and environmental components of this technology make it stand out and give it that competitive edge to succeed across all sectors. Clean air will be pivotal in safely reopening retail stores, schools, public transport, office buildings, and any major public space. But beyond the short term of getting back to normal and existing in a world without COVID, it will be life changing for the health and wellness of everyday people who may be predisposed to allergens, bacteria, and other ultra fine particles.
We are truly exhausting all efforts to make sure that we can prevent and minimize the risk of major illnesses. The long-term vision is for this technology to be integrated into cars, airplanes – to be a vital player in our safe travel. COVID might be the threat today, but who knows what it will be tomorrow. The Atmofizer makes sure we are ready for whatever they might be.
Check out: Atmofizer
